Eurobio-Scientific
Eurobio-Scientific is a French specialty diagnostics company that develops, manufactures, and distributes in vitro diagnostic products across transplantation, oncology, infectious diseases, and life sciences, serving transplant centers, clinical laboratories, and hospital systems in more than 10 countries through proprietary products and an acquired distribution network.
- Company typePublic
- Founded1999
- HeadquartersEssonnes, France
- Headcount251–500
- GTM typeB2B
- OfferingHardware or Manufacturing
What Eurobio-Scientific does
Eurobio-Scientific is a French specialty diagnostics company, publicly traded on Euronext Paris (ticker ALXP) and headquartered in Les Ulis, France. The company develops, manufactures, and distributes in vitro diagnostic (IVD) products across four therapeutic verticals: Transplantation (GenDx HLA typing reagents and chimerism monitoring kits), Oncology (EndoPredict breast cancer genomic test, Prolaris prostate cancer test, and companion diagnostic services), Infectious Diseases (EurobioPlex real-time PCR kits and TECO FungiLine rapid fungal diagnostics), and Life Sciences (cell culture media, ELISA kits, molecular biology reagents, and immunology antibodies). Core technologies span PCR, next-generation sequencing, ELISA, lateral flow assays, and corneal organoculture media, with manufacturing operations in France (Les Ulis) and the Netherlands (Utrecht).
The business operates a hybrid revenue model combining proprietary product sales — representing approximately 35% of FY2025 revenue — with distribution of third-party diagnostic products (Seegene multiplex PCR, ABL Diagnostics, CareDx products pre-acquisition) through owned subsidiaries and channel partners. Approximately 42% of sales are generated outside France. The customer base spans transplant centers and HLA laboratories, hospital systems, clinical pathology laboratories, and life sciences researchers, served through direct enterprise sales for specialized products (HLA typing, oncology) and an extensive distributor network built through over 50 acquisitions. Distribution is concentrated in Europe (France, Italy, Netherlands, Germany, UK, Switzerland, Austria, Belgium) with North American and Oceania operations.
Recent strategic activity has been heavily acquisition-driven, with the €135 million GenDx acquisition in 2022 establishing proprietary transplantation diagnostics, the 2023 DID acquisition anchoring Italian IVD distribution, the 2025 Voden/Quimark Italian consolidation, and a pending $170 million acquisition of CareDx's Lab Products division announced in April 2026. The company holds CE-IVD, ISO 13485, and ISO 9001 certifications across multiple entities and operates in more than 10 countries through owned affiliates.
Eurobio-Scientific firmographics
Firmographics- Name
- Eurobio-Scientific
- Legal name
- Eurobio Scientific
- Website
- https://www.eurobio-scientific.com/
- Company type
- Public
- Founded year
- 1999
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- Eurobio-Scientific is a French specialty diagnostics company that develops, manufactures, and distributes in vitro diagnostic products across transplantation, oncology, infectious diseases, and life sciences, serving transplant centers, clinical laboratories, and hospital systems in more than 10 countries through proprietary products and an acquired distribution network.
- Ownership category
- akta.pro rank
Eurobio-Scientific industry classification
Industry- Product category
- In Vitro Diagnostics
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413), Medical Equipment and Supplies Manufacturing (3391)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
- akta.pro primary industry
- IVD Reagents, Assay Kits & Consumables (Non-instrument) (HLAHAAAM)
- akta.pro secondary industry
- Quality Control, Calibrators, Standards & Proficiency Testing (IVD Consumables) (HLAHAAAL)
Keywords
Where Eurobio-Scientific is headquartered
LocationHeadquarters
- HQ city
- Essonnes
- HQ country
- France
- HQ region
- Europe
Offices4 records
Markets served
Eurobio-Scientific business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales, Others
Revenue model
- Product Sales - IVD and Diagnostic Instruments: Sale of in vitro diagnostic instruments, reagents, and test kits directly to laboratories, hospitals, and transplant centers. Revenue generated from proprietary diagnostic products and distributed branded products.
- Distribution Revenue: Revenue from distributing third-party diagnostic products through acquired distributor networks in Italy and other regions, earning margins on resale of products from partners including Seegene and ABL Diagnostics.
- Acquisition Integration - Regional Expansion: Revenue growth driven by strategic acquisitions of diagnostic distributors (DID Italy, Quimark SRL, Voden Medical Instruments), expanding geographic footprint and customer base across European markets.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Enterprise diagnostic instrument and reagent contracts |
Go-to-market motion3 records
Distribution channels5 records
Marketing channels5 records
Eurobio-Scientific product offering
Product offeringCore offering
Eurobio-Scientific develops, manufactures, and distributes specialty in vitro diagnostic (IVD) products for clinical laboratories, hospitals, and transplant centers across four areas: transplantation (HLA typing kits, chimerism monitoring, cornea preservation media), oncology (EndoPredict breast cancer and Prolaris prostate cancer genomic tests), infectious diseases (multiplex PCR kits, fungal antigen assays), and life sciences (cell culture media, ELISA kits, molecular biology reagents). The company also offers companion diagnostic development services and distributes third-party IVD brands through acquired regional affiliates in Europe, North America, and Asia-Pacific.
Product overview
Eurobio Scientific is a specialty diagnostics company that develops, produces, and distributes in vitro diagnostic products for clinical use. The portfolio comprises proprietary and distributed products across four main therapeutic areas: Transplantation (GenDx HLA typing and chimerism monitoring reagents with NGSengine/KMRengine analysis software, plus cornea preservation media), Oncology (EndoPredict breast cancer and Prolaris prostate cancer genomic tests, plus companion diagnostic development services), Infectious Diseases (EurobioPlex real-time PCR kits for respiratory/vector-borne infections, TECO FungiLine rapid fungal diagnostics, and TQS tetanus rapid tests), and Life Sciences (cell culture media, PKA biosafety assays, ELISA kits, molecular biology reagents, immunology antibodies, and PathTROL quality controls). The company operates manufacturing sites in France (Les Ulis) and the Netherlands (Utrecht), with distribution across more than 10 countries through local affiliates.
Differentiator
Problem solved
Functional benefit
Brands
- EndoPredict: Genomic test for breast cancer prognosis and chemotherapy benefit prediction for ER-positive, HER2-negative early-stage breast cancer
- Prolaris
- GenDx
- EurobioPlex
- TECO
- PathTROL
- CorneaMax/CorneaPrep
- DID (Diagnostic International Distribution)
Products and services
- GenDx Product Portfolio Proprietary molecular diagnostic product portfolio for transplantation including NGS-based HLA typing reagents (NGSgo, NGS-Turbo, NGSgo-AmpX, NGSgo-MX6-1, NGSgo-MX11-3, NGSgo-ProntoFLX, NGSgo-ProntoAmp), chimerism monitoring kits (KMRtype, KMRtrack, NGStrack), and analysis software (NGSengine, KMRengine, TRKengine) for transplant matching and post-transplant surveillance. Sold to transplant centers and HLA laboratories.
- Cornea Product Portfolio
Quantifiable outcome
- GenDx acquisition for €135 million represents company's largest transaction, expanding molecular diagnostics capabilities
- +1 more outcomes
Companies that use Eurobio-Scientific
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles3 records
Eurobio-Scientific technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
Feature3 records
Eurobio-Scientific partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core and minor.
- CareDxcoreAcquisition of CareDx's Lab Products division by Eurobio Scientific, including the KMRtract and KMRtype product lines for transplantation diagnostics. CareDx received €42 million initial payment plus additional earnout. Eurobio Scientific gained full ownership of transplantation testing products previously distributed through GenDx.
- GenDxcoreGenDx, acquired for €135 million, is a leader in molecular diagnostics for transplantation (HLA typing). The acquisition provided Eurobio Scientific with proprietary NGS-based HLA typing technology and established the company as a leader in transplantation molecular diagnostics in Europe.
- DID (Diagnostic International Distribution)coreAcquisition of DID, a leading Italian diagnostic distribution company, expanding Eurobio Scientific's presence in the Italian market. DID had been a long-standing distributor for Eurobio products and other major in vitro diagnostics manufacturers.
- Quimark SRLminorAcquisition of Quimark SRL, an Italian diagnostic distributor specializing in immunology and molecular diagnostics products. Expansion of Italian subsidiary operations.
- Voden Medical Instruments SpacoreAcquisition of Voden Medical Instruments Spa, based in Lodi, Italy, further expanding Eurobio Scientific's Italian distribution network and customer base in clinical diagnostics.
- SeegenecoreStrategic partnership with South Korean molecular diagnostics company Seegene for distribution of Seegene's multiplex PCR-based diagnostic products. Seegene provides proprietary molecular diagnostics technology including automated sample preparation and syndromic testing panels.
- ABL DiagnosticsminorDistribution agreement with ABL Diagnostics for infectious disease diagnostic products. Eurobio Scientific distributes ABL Diagnostics' molecular diagnostic assays for infectious diseases through its European distribution network.
Scale indicators4 records
Recent moves6 records
Expansion highlights6 records
Eurobio-Scientific competitors and assessment
Company assessmentBroad incumbents
- bioMérieux: Global leader in in vitro diagnostics headquartered in France, with a broad microbiology and molecular diagnostics portfolio. Directly comparable to Eurobio as a French-headquartered IVD specialist and a likely benchmark for European specialty diagnostics multiples.
- QIAGEN: Global molecular diagnostics and sample technologies leader with deep presence in PCR, HLA/ transplantation workflows, and infectious disease. Comparable to Eurobio's GenDx transplant and EurobioPlex infectious disease PCR lines, though at much larger scale.
- Hologic: US diagnostics and women's health company with a large molecular diagnostics franchise (Panther platform, Aptima assays). Comparable to Eurobio's infectious disease PCR portfolio in scale of molecular content and customer base.
Direct peers
- DiaSorin: Italian-headquartered specialty IVD company focused on immunodiagnostics and molecular diagnostics with strong European distribution. Comparable to Eurobio in European specialty IVD positioning, scale, and proprietary-plus-distribution business model.
- Seegene: South Korean molecular diagnostics company specializing in multiplex syndromic PCR testing. Direct partner and content supplier to Eurobio; comparable multiplex PCR technology competes in the same infectious disease menu space as EurobioPlex.
- CareDx: US-based transplant diagnostics specialist whose Lab Products division Eurobio is acquiring for $170M. Highly comparable in transplant HLA typing and chimerism monitoring, and will continue to overlap in post-transplant monitoring where CareDx retains North American rights.
- Immucor: Transfusion and transplantation diagnostics company specializing in HLA typing and blood banking reagents. Directly comparable to GenDx in transplant HLA and chimerism testing, and competes for the same transplant-center customers as Eurobio's GenDx line.
- ELITech Group: European specialty IVD company with broad chemistry, immunoassay, and molecular diagnostics menus distributed via local affiliates. Comparable to Eurobio in mid-size European specialty IVD positioning and channel-partner-led commercial model.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Eurobio-Scientific social profiles
Digital presenceEurobio-Scientific compliance and trust
Trust signalCompliance3 records
Eurobio-Scientific financial estimates
Financial estimateRevenue estimate
Valuation estimate
Eurobio-Scientific leadership team
Management profileNumber of profiles
Profiles2 records
Eurobio-Scientific subsidiaries and ownership
Company hierarchySubsidiaries14 records
Eurobio-Scientific funding detail
Funding detailFunding overview
Funding rounds2 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Eurobio-Scientific M&A and investment
M&A and investmentM&A9 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Eurobio-Scientific
What does Eurobio-Scientific do?
Eurobio-Scientific develops, manufactures, and distributes specialty in vitro diagnostic (IVD) products for clinical laboratories, hospitals, and transplant centers across four areas: transplantation (HLA typing kits, chimerism monitoring, cornea preservation media), oncology (EndoPredict breast cancer and Prolaris prostate cancer genomic tests), infectious diseases (multiplex PCR kits, fungal antigen assays), and life sciences (cell culture media, ELISA kits, molecular biology reagents). The company also offers companion diagnostic development services and distributes third-party IVD brands through acquired regional affiliates in Europe, North America, and Asia-Pacific.
Is Eurobio-Scientific a public or private company?
Eurobio-Scientific is a public company. It is classified as public and is currently operating.
When was Eurobio-Scientific founded?
Eurobio-Scientific was founded in 1999. It employs 251 to 500 people.
Where is Eurobio-Scientific based?
Eurobio-Scientific is headquartered in Essonnes, France, in the Europe region.
How does Eurobio-Scientific make money?
Three revenue lines are on record. Product Sales - IVD and Diagnostic Instruments are the primary driver. The others are distribution Revenue and acquisition Integration - Regional Expansion.
Who are Eurobio-Scientific's main competitors?
Broad incumbents on record are bioMérieux, QIAGEN and Hologic. Direct peers are DiaSorin, Seegene, CareDx, Immucor and ELITech Group.
Does Eurobio-Scientific have an API?
No public API is recorded for Eurobio-Scientific.
What industry is Eurobio-Scientific in?
Eurobio-Scientific's product category is In Vitro Diagnostics. Its primary akta.pro industry code is HLAHAAAM, IVD Reagents, Assay Kits & Consumables (Non-instrument), with a secondary code of HLAHAAAL, Quality Control, Calibrators, Standards & Proficiency Testing (IVD Consumables). Its NAICS code is 325413 and its SIC code is 2835.